Wegovy Pill Becomes First Oral GLP 1 Weight Loss Drug Approved in U.S. Scientific American The Multifaceted Nature of GLP 1: Molecular Mechanisms and Signaling Pathways in Metabolic and Neurodegenerative Diseases Are there natural alternatives to GLP1 agonists? Acting on three hormonal pathways at once, an experimental medication called retatrutide produced sizeable drops in both blood sugar and body weight during a late stage clinical trial, with results now published in